1. Home
  2. News
  3. Mesoblast Limited
  4. Becoming a substantial holder
More Mesoblast Limited news
Mesoblast LimitedASX: MSB

Becoming a substantial holder

Jul 31, 2026 at 3:06 AM EDT · Issued by Mesoblast Limited via ASX

Filed with ASX · Jul 31, 2026 at 3:06 AM EDT

On 6ix: 6ix.com/news/becoming-a-substantial-holder-352

603 Page 1 31-Jul-2026 To Company Name/Scheme ACN/ARSN 1. Details of substantial holder (1) Name ACN/ARSN (if applicable) The holder became a substantial holder on 29/07/2026 2. Details of voting power The total number of votes attached to all the voting shares in the company or voting...

View Attachment

6ix hasn’t read this filing yet.

Mesoblast Limited on 6ix

Earlier from Mesoblast

  • Quarterly Activities/Appendix 4C Cash Flow ReportJul 29
  • Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product LaunchJul 29
  • Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back PainJul 13
  • Pivotal Phase 3 Trial in CLBP Achieves 300 Treated PatientsJul 13
  • Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026Jul 9

Later from Mesoblast

  • Ceasing to be a substantial holderAug 3
  • Major Milestone Treatment Completed in P3 Trial for CLBPAug 16
  • Mesoblast 2026 Full Year Financial Results WebcastAug 24
  • Notification regarding unquoted securities - MSBAug 24
  • Appendix 3Y - Philip KrauseAug 24
All Mesoblast news releases↗
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer